Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00134706
What this trial is testing

Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 30
Early research (Phase 1)Study completedNCT00305747
What this trial is testing

Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 12
Testing effectiveness (Phase 2)Ended earlyNCT00351858
What this trial is testing

Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsBreast Cancer
Neovii Biotech 40
Large-scale testing (Phase 3)UnknownNCT05390255
What this trial is testing

Establishment of Precise Diagnosis and Treatment System for Refractory Chronic Rhinosinusitis

Who this might be right for
Sinusitis
Beijing Tongren Hospital 87
Large-scale testing (Phase 3)Study completedNCT00036556
What this trial is testing

Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Abbott 941
Testing effectiveness (Phase 2)Study completedNCT00003670
What this trial is testing

Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Eli Lilly and Company
Testing effectiveness (Phase 2)Ended earlyNCT00447473
What this trial is testing

Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 31
Testing effectiveness (Phase 2)Ended earlyNCT02480010
What this trial is testing

Pertuzumab in Participants With Prostate Cancer

Who this might be right for
Prostate Cancer
Hoffmann-La Roche 68
Testing effectiveness (Phase 2)UnknownNCT00218205
What this trial is testing

Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer
Department of Veterans Affairs, New Jersey 28
Early research (Phase 1)Looking for participantsNCT05997615
What this trial is testing

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Who this might be right for
Hormone-refractory Prostate Cancer
Astellas Pharma Global Development, Inc. 437
Early research (Phase 1)Study completedNCT00082732
What this trial is testing

Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 56
Testing effectiveness (Phase 2)Study completedNCT00093457
What this trial is testing

Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 28
Testing effectiveness (Phase 2)Study completedNCT01906372
What this trial is testing

Acthar in Treatment of Refractory Dermatomyositis and Polymyositis

Who this might be right for
DermatomyositisPolymyositis
Rohit Aggarwal, MD 12
Testing effectiveness (Phase 2)Study completedNCT00005847
What this trial is testing

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Study completedNCT01133704
What this trial is testing

Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer

Who this might be right for
Hormone-Refractory Prostate Cancer
Dendreon 98
Testing effectiveness (Phase 2)Study completedNCT00284752
What this trial is testing

Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Kaiser Permanente 56
Testing effectiveness (Phase 2)Study completedNCT03394027
What this trial is testing

ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma

Who this might be right for
Triple Negative Breast CancerEndometrial CancerHormone Receptor Positive, HER2 Negative Breast Cancer
National Cancer Institute (NCI) 30
Early research (Phase 1)Looking for participantsNCT05098210
What this trial is testing

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more
Fred Hutchinson Cancer Center 28
Large-scale testing (Phase 3)Ended earlyNCT01083615
What this trial is testing

A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Who this might be right for
Castrate-Resistant Prostate CancerHormone Refractory Prostate Cancer
Achieve Life Sciences 14
Testing effectiveness (Phase 2)Study completedNCT00005810
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 40
Next Page